{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T20:36:03Z","timestamp":1789763763959,"version":"4.0.1"},"reference-count":43,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1097\/wnf.0b013e31823429a7","type":"journal-article","created":{"date-parts":[[2011,10,13]],"date-time":"2011-10-13T05:23:21Z","timestamp":1318483401000},"page":"248-255","source":"Crossref","is-referenced-by-count":81,"title":["Thyroid Adverse Effects of Psychotropic Drugs"],"prefix":"10.1097","volume":"34","author":[{"given":"Rami","family":"Bou Khalil","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sami","family":"Richa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"issue":"6","key":"R2-9-20210203","doi-asserted-by":"crossref","first-page":"e16","DOI":"10.4088\/JCP.0608e16","article-title":"Medical monitoring in patients with bipolar disorder: a review of data.","volume":"69","author":"Fagiolini","year":"2008","journal-title":"J Clin Psychiatry"},{"issue":"1","key":"R8-9-20210203","doi-asserted-by":"crossref","first-page":"80","DOI":"10.4088\/JCP.v66n0111","article-title":"Thyroid function in treatment-resistant schizophrenia patients treated with quetiapine, risperidone, or fluphenazine.","volume":"66","author":"Kelly","year":"2005","journal-title":"J Clin Psychiatry"},{"key":"R9-9-20210203","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1471-244X-4-6","article-title":". Thyroid function in clinical subtypes of major depression: an exploratory study.","volume":"4","author":"Fountoulakis","year":"2004","journal-title":"BMC Psychiatry"},{"issue":"2","key":"R10-9-20210203","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3109\/15622970109027495","article-title":"Thyroid hormone, neural tissue and mood modulation.","volume":"2","author":"Bauer","year":"2001","journal-title":"World J Biol Psychiatry"},{"issue":"4","key":"R12-9-20210203","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1097\/YCO.0b013e328329e1ae","article-title":"Thyroid disorders in mental patients.","volume":"22","author":"Bunevicius","year":"2009","journal-title":"Curr Opin Psychiatry"},{"issue":"6","key":"R16-9-20210203","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.beem.2009.06.002","article-title":"Lithium and thyroid.","volume":"23","author":"Lazarus","year":"2009","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"3","key":"R17-9-20210203","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1002\/cpt1969103350","article-title":"Chlorpromazine-procyclidine and imipramine: effects on thyroid function in psychiatric patients.","volume":"10","author":"Blumberg","year":"1969","journal-title":"Clin Pharmacol Ther"},{"key":"R18-9-20210203","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1001\/jama.1963.03060090058022","article-title":"Protein-bound iodine in patients receiving perphenazine.","volume":"185","author":"Oltman","year":"1963","journal-title":"JAMA"},{"issue":"2","key":"R19-9-20210203","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0022-3565(25)11670-4","article-title":"The direct antithyroid action of reserpine, chlorpromazine and other drugs.","volume":"117","author":"Mayer","year":"1956","journal-title":"J Pharmacol Exp Ther"},{"key":"R20-9-20210203","first-page":"371","article-title":". Effect of chlorpromazine on thyroid activity.","volume":"14","author":"Foldes","year":"1959","journal-title":"Acta Med Acad Sci Hung"},{"issue":"3","key":"R22-9-20210203","first-page":"249","article-title":"Neurotransmitter regulation of anterior pituitary hormones.","volume":"37","author":"Tuomisto","year":"1985","journal-title":"Pharmacol Rev"},{"issue":"3","key":"R26-9-20210203","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/00004850-199100630-00001","article-title":"Neuroleptic actions on the thyroid axis: different effects of clozapine and haloperidol.","volume":"6","author":"Paunovic","year":"1991","journal-title":"Int Clin Psychopharmacol"},{"issue":"4","key":"R27-9-20210203","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1345\/aph.19186","article-title":"Possible hypothyroidism associated with quetiapine.","volume":"34","author":"Feret","year":"2000","journal-title":"Ann Pharmacother"},{"issue":"1","key":"R29-9-20210203","doi-asserted-by":"crossref","first-page":"80","DOI":"10.4088\/JCP.v66n0111","article-title":"Thyroid function in treatment-resistant schizophrenia patients treated with quetiapine, risperidone, or fluphenazine.","volume":"66","author":"Kelly","year":"2005","journal-title":"J Clin Psychiatry"},{"issue":"6","key":"R32-9-20210203","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/0006-3223(89)90241-2","article-title":"The thyroid axis and desipramine treatment in depression.","volume":"25","author":"Brady","year":"1989","journal-title":"Biol Psychiatry"},{"issue":"2","key":"R33-9-20210203","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1055\/s-2007-1014485","article-title":"The effect of tricyclic antidepressants on basal thyroid hormone levels in depressed patients.","volume":"23","author":"Joffe","year":"1990","journal-title":"Pharmacopsychiatry"},{"issue":"2","key":"R34-9-20210203","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1055\/s-2007-1019567","article-title":"Nortriptyline and pituitary-thyroid function in affective disorder.","volume":"14","author":"Nordgren","year":"1981","journal-title":"Pharmacopsychiatria"},{"issue":"1-2","key":"R38-9-20210203","first-page":"45","article-title":"Thyroid hormones, the brain, and affective disorders.","volume":"8","author":"Joffe","year":"1994","journal-title":"Crit Rev Neurobiol"},{"issue":"2","key":"R39-9-20210203","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1017\/S1461145700001887","article-title":"Thyroxine and the treatment of affective disorders: an overview of the results of basic and clinical research.","volume":"3","author":"Baumgartner","year":"2000","journal-title":"Int J Neuropsychopharmacol"},{"issue":"12","key":"R45-9-20210203","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1592\/phco.21.20.1574.34483","article-title":"Evaluation of the association between St. Johns wort and elevated thyroid-stimulating hormone.","volume":"21","author":"Ferko","year":"2001","journal-title":"Pharmacotherapy"},{"issue":"11","key":"R46-9-20210203","first-page":"1519","article-title":"Lithium accumulation in some endocrine tissues.","volume":"35","author":"Pfeifer","year":"1976","journal-title":"Acta Biol Med Ger"},{"issue":"2","key":"R50-9-20210203","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1530\/acta.0.1060203","article-title":"Sex related goitrogenic effect of lithium carbonate in healthy young subjects.","volume":"106","author":"Perrild","year":"1984","journal-title":"Acta Endocrinol (Copenh)"},{"issue":"3","key":"R54-9-20210203","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0002-9343(89)80168-8","article-title":"Myxedema coma associated with lithium therapy.","volume":"87","author":"Waldman","year":"1989","journal-title":"Am J Med"},{"issue":"1","key":"R56-9-20210203","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/j.1600-0447.1995.tb09741.x","article-title":"Renal, thyroid and parathyroid function during lithium treatment: laboratory tests in 207 people treated for 1-30 years.","volume":"91","author":"Kallner","year":"1995","journal-title":"Acta Psychiatr Scand"},{"issue":"1","key":"R57-9-20210203","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0165-0327(98)00028-7","article-title":"Thyroid disorders in lithium-treated patients.","volume":"50","author":"Kirov","year":"1998","journal-title":"J Affect Disord"},{"key":"R59-9-20210203","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1192\/bjp.175.4.336","article-title":"Lithium-associated clinical hypothyroidism. Prevalence and risk factors.","volume":"175","author":"Johnston","year":"1999","journal-title":"Br J Psychiatry"},{"issue":"4","key":"R65-9-20210203","first-page":"207","article-title":"Thyroid disorders induced by lithium and amiodarone: an overview.","volume":"9","author":"Chow","year":"1990","journal-title":"Adverse Drug React Acute Poisoning Rev"},{"issue":"4","key":"R67-9-20210203","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1046\/j.1365-2265.2001.01381.x","article-title":"Association between lithium use and thyrotoxicosis caused by silent thyroiditis.","volume":"55","author":"Miller","year":"2001","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"3","key":"R68-9-20210203","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1365-2265.1978.tb01493.x","article-title":"Thyroid function tests in patients on long-term treatment with various anticonvulsant drugs.","volume":"8","author":"Liewendahl","year":"1978","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"R69-9-20210203","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/j.1528-1157.1992.tb02297.x","article-title":"Thyroid function with antiepileptic drugs.","volume":"33","author":"Isojarvi","year":"1992","journal-title":"Epilepsia"},{"issue":"2","key":"R70-9-20210203","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1210\/edrv-12-2-135","article-title":"The effect of hepatic enzyme-inducing drugs on thyroid hormones and the thyroid gland.","volume":"12","author":"Curran","year":"1991","journal-title":"Endocr Rev"},{"issue":"5","key":"R72-9-20210203","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1600-0404.2007.00883.x","article-title":"Carbamazepine and risk of hypo-thyroidism: a prospective study.","volume":"116","author":"Simko","year":"2007","journal-title":"Acta Neurol Scand"},{"issue":"4","key":"R76-9-20210203","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/j.1600-0404.1983.tb04569.x","article-title":"Serum thyroid hormones and blood folic acid during monotherapy with carbamazepine or valproate.","volume":"67","author":"Bentsen","year":"1983","journal-title":"Acta Neurol Scand"},{"issue":"5543","key":"R78-9-20210203","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1136\/bmj.2.5543.52-a","article-title":"Drugs and thyroid-function tests.","volume":"2","author":"Harvey","year":"1967","journal-title":"Br Med J"},{"issue":"8","key":"R79-9-20210203","first-page":"379","article-title":"Pharmacology for the dental practitioner. 8. Drug interactions, drug-induced diseases and drugs in pregnancy.","volume":"127","author":"Walton","year":"1969","journal-title":"Br Dent J"},{"issue":"6","key":"R80-9-20210203","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1097\/00000441-196906000-00005","article-title":"Diazepam (Valium) and thyroid function: a double-blind, placebo controlled study in normal volunteers showing no drug effect.","volume":"257","author":"Mazzaferri","year":"1969","journal-title":"Am J Med Sci"},{"issue":"3","key":"R81-9-20210203","first-page":"134","article-title":"Diazepam (Valium(R)) in thyrotoxicosis. Negative results.","volume":"126","author":"Greenberg","year":"1970","journal-title":"Johns Hopkins Med J"},{"issue":"5749","key":"R82-9-20210203","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1136\/bmj.1.5749.585","article-title":"Diazepam and tests of thyroid function.","volume":"1","author":"Clark","year":"1971","journal-title":"Br Med J"},{"issue":"6","key":"R83-9-20210203","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1210\/jcem-37-6-928","article-title":"Increased serum thyroxine levels in euthyroid narcotic addicts.","volume":"37","author":"Webster","year":"1973","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"R84-9-20210203","doi-asserted-by":"crossref","first-page":"366","DOI":"10.7326\/0003-4819-98-3-366","article-title":"Euthyroid hyperthyroxinemia.","volume":"98","author":"Borst","year":"1983","journal-title":"Ann Intern Med"},{"issue":"2","key":"R85-9-20210203","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1445-5994.1985.tb04036.x","article-title":"The diagnostic challenge of euthyroid hyperthyroxinemia.","volume":"15","author":"Stockigt","year":"1985","journal-title":"Aust N Z J Med"},{"issue":"11","key":"R86-9-20210203","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1093\/clinchem\/34.11.2202","article-title":"Abnormalities in thyroid function associated with chronic therapy with methadone.","volume":"34","author":"English","year":"1988","journal-title":"Clin Chem"},{"key":"R95-9-20210203","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.arcmed.2004.11.007","article-title":". Association between systemic lupus erythematosus, rheumatoid arthritis, hyperprolactinemia and thyroid autoantibodies.","volume":"36","author":"Kramer","year":"2005","journal-title":"Arch Med Res"}],"container-title":["Clinical Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/WNF.0b013e31823429a7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T17:08:44Z","timestamp":1741799324000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002826-201111000-00009"}},"subtitle":["A Review"],"short-title":[],"issued":{"date-parts":[[2011,11]]},"references-count":43,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/wnf.0b013e31823429a7","relation":{},"ISSN":["0362-5664"],"issn-type":[{"value":"0362-5664","type":"print"}],"subject":[],"published":{"date-parts":[[2011,11]]}}}